Related references
Note: Only part of the references are listed.Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
Silvia Bertagnolio et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Impact of pre-existing drug resistance on risk of virological failure in South Africa
Jonathan Z. Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Shahin Lockman et al.
LANCET (2021)
Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States
Emily P. Hyle et al.
CLINICAL INFECTIOUS DISEASES (2020)
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
Esaú C João et al.
Lancet HIV (2020)
Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
Kenneth Kintu et al.
LANCET HIV (2020)
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
Mark J. Siedner et al.
NATURE COMMUNICATIONS (2020)
Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
Ingrid A. Beck et al.
ECLINICALMEDICINE (2020)
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
Willem D. F. Venter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1
A. Ayouba et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial
Laurent Hocqueloux et al.
CLINICAL INFECTIOUS DISEASES (2019)
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial
Jose L. Blanco et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals
Monica B. Arruda et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)
HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa
L. Myer et al.
HIV MEDICINE (2017)
Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014
Rachel A. Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial
Ingeborg Wijting et al.
LANCET HIV (2017)
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction
Lisa Rahangdale et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
Rami Kantor et al.
CLINICAL INFECTIOUS DISEASES (2015)
Moderate Prevalence of Transmitted Drug Resistance Mutations Among Antiretroviral-Naive HIV-Infected Pregnant Women in Rio de Janeiro, Brazil
Jose H. Pilotto et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
Rapid Decline in HIV Viral Load When Introducing Raltegravir-Containing Antiretroviral Treatment Late in Pregnancy
Katarina Westling et al.
AIDS PATIENT CARE AND STDS (2012)
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
Raph L. Hamers et al.
LANCET INFECTIOUS DISEASES (2012)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
Rationale and uses of a public HIV drug-resistance database
Robert W. Shafer
JOURNAL OF INFECTIOUS DISEASES (2006)
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee et al.
NUCLEIC ACIDS RESEARCH (2003)
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/mL
JPA Ioannidis et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1
M Lallemant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
